z-logo
open-access-imgOpen Access
Older High-Risk MDS Patients Should Be Offered Curative Transplant
Author(s) -
Mark L. Fuerst
Publication year - 2021
Publication title -
oncology times
Language(s) - English
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000735176.39826.8e
Subject(s) - medicine , transplantation , medicaid , myelodysplastic syndromes , hematopoietic stem cell transplantation , hematopoietic cell , quality of life (healthcare) , pediatrics , stem cell , intensive care medicine , haematopoiesis , health care , bone marrow , nursing , biology , economics , genetics , economic growth

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here